Live News Categoriesmarket

KAPA.A (KAPA.A) News

Follow KAPA.A (KAPA.A) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol KAPA.A Asset market Sector Markets 90 days 1 Updated Oct 06, 2026, 11:31 AM UTC Open live news feed

M Kairos Pharma reports positive interim efficacy data in prostate cancer trial Kairos Pharma announced positive interim efficacy data from its Phase 2 trial of ENV-105 in combination with apalutamide for metastatic prostate cancer, showing a statistically significant difference in progression-free EQUITY | Oct 06, 2026, 11:31 AM UTC